The potential utility of green tea extract as a novel treatment for cutaneous leishmaniasis.
Feily
Amir
A
Yaghoobi
Reza
R
Namazi
Mohammad Reza
MR
D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D028241:Camellia sinensis / Q000737:chemistry*; D004351:Drug Resistance; D005419:Flavonoids / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007891:Leishmania / Q000187:drug effects* / Q000378:metabolism; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000378:metabolism; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D010636:Phenols / Q000494:pharmacology / Q000627:therapeutic use*; D008517:Phytotherapy; D010936:Plant Extracts / Q000494:pharmacology / Q000627:therapeutic use*; D059808:Polyphenols; D013662:Tea
D000981:Antiprotozoal Agents; D005419:Flavonoids; D009942:Organometallic Compounds; D010636:Phenols; D010936:Plant Extracts; D059808:Polyphenols; D013662:Tea; D008536:Meglumine; D000077485:Meglumine Antimoniate